BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time

Rhea-AI Summary

BioLargo, Inc. (OTCQX:BLGO), a sustainable technology developer and environmental engineering company, has announced an investor webcast and conference call scheduled for Wednesday, August 14, 2024, at 1:30 PM Pacific Time. The event will review the company's financial results for Q2 2024, discuss recent milestones, and include a Q&A session. Participants can join via webcast or teleconference, with replay options available until August 28 for teleconference and November 14 for webcast. This event provides an opportunity for investors and the public to gain insights into BioLargo's performance and future outlook.

WESTMINSTER, CA / ACCESSWIRE / August 13, 2024 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Wednesday, August 14, 2024 at 1:30 pm Pacific Time / 4:30 pm Eastern Time. The event, which will be open to the public, will be held to review the company's financial results for the three months and six months ended June 30, 2024, discuss recent milestones, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.

To participate in the live webcast and teleconference:

Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/51101
Teleconference Domestic: 877-545-0523
Teleconference International: 973-528-0016
Participant Access Code: 739107

To watch or listen to a replay of the webcast or teleconference:

Teleconference Replay Expiration: August 28, 2024
Webcast Replay Expiration: November 14, 2024
Teleconference Replay Domestic: 877-481-4010
Teleconference Replay International: 919-882-2331
Replay Passcode: 51101

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") anticipated revenue and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Contact Information

Dennis Calvert
President and CEO
dennis.calvert@biolargo.com
(949) 235-8062

SOURCE: BioLargo, Inc.

View the original press release on accesswire.com

FAQ

When is BioLargo's (BLGO) Q2 2024 earnings call scheduled?

BioLargo's Q2 2024 earnings call is scheduled for Wednesday, August 14, 2024, at 1:30 PM Pacific Time / 4:30 PM Eastern Time.

How can investors participate in BioLargo's (BLGO) upcoming earnings call?

Investors can participate in BioLargo's earnings call via webcast at https://www.webcaster4.com/Webcast/Page/2448/51101 or by teleconference using the domestic number 877-545-0523 or international number 973-528-0016 with participant access code 739107.

What period will BioLargo's (BLGO) upcoming earnings report cover?

BioLargo's upcoming earnings report will cover the financial results for the three months and six months ended June 30, 2024.

How long will the replay of BioLargo's (BLGO) Q2 2024 earnings call be available?

The teleconference replay will be available until August 28, 2024, while the webcast replay will be accessible until November 14, 2024.